BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 8863822)

  • 41. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
    Spracklin DK; Thummel KE; Kharasch ED
    Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of the NPTA element of the CYP2A3 gene by NFI-A2, a nasal mucosa-selective nuclear factor 1 isoform.
    Xie Y; Madelian V; Zhang J; Ling G; Ding X
    Biochem Biophys Res Commun; 2001 Dec; 289(5):1225-8. PubMed ID: 11741324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytochrome P450 species involved in the metabolism of quinoline.
    Reigh G; McMahon H; Ishizaki M; Ohara T; Shimane K; Esumi Y; Green C; Tyson C; Ninomiya S
    Carcinogenesis; 1996 Sep; 17(9):1989-96. PubMed ID: 8824525
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preferential metabolic activation of N-nitrosopiperidine as compared to its structural homologue N-nitrosopyrrolidine by rat nasal mucosal microsomes.
    Wong HL; Murphy SE; Hecht SS
    Chem Res Toxicol; 2003 Oct; 16(10):1298-305. PubMed ID: 14565771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Specificity of cytochrome P450 2A3-catalyzed alpha-hydroxylation of N'-nitrosonornicotine enantiomers.
    Murphy SE; Isaac IS; Ding X; McIntee EJ
    Drug Metab Dispos; 2000 Nov; 28(11):1263-6. PubMed ID: 11038149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. cDNA cloning, heterologous expression, and characterization of mouse CYP2G1, an olfactory-specific steroid hydroxylase.
    Hua Z; Zhang QY; Su T; Lipinskas TW; Ding X
    Arch Biochem Biophys; 1997 Apr; 340(2):208-14. PubMed ID: 9143323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes.
    Li Y; Li NY; Sellers EM
    Eur J Drug Metab Pharmacokinet; 1997; 22(4):295-304. PubMed ID: 9512924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat.
    Kobayashi K; Urashima K; Shimada N; Chiba K
    Biochem Pharmacol; 2002 Mar; 63(5):889-96. PubMed ID: 11911841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of cytochrome P450 2A4 and 2A5-catalyzed 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism.
    Felicia ND; Rekha GK; Murphy SE
    Arch Biochem Biophys; 2000 Dec; 384(2):418-24. PubMed ID: 11368333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Roles of human CYP2A6 and rat CYP2B1 in the oxidation of (+)-fenchol by liver microsomes.
    Miyazawa M; Gyoubu K
    Xenobiotica; 2007 Sep; 37(9):943-53. PubMed ID: 17992728
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CYP2A6: a human coumarin 7-hydroxylase.
    Pelkonen O; Rautio A; Raunio H; Pasanen M
    Toxicology; 2000 Apr; 144(1-3):139-47. PubMed ID: 10781881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of human cytochrome P4502A6 in C-oxidation of nicotine.
    Nakajima M; Yamamoto T; Nunoya K; Yokoi T; Nagashima K; Inoue K; Funae Y; Shimada N; Kamataki T; Kuroiwa Y
    Drug Metab Dispos; 1996 Nov; 24(11):1212-7. PubMed ID: 8937855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes.
    Yamazaki H; Inoue K; Hashimoto M; Shimada T
    Arch Toxicol; 1999 Mar; 73(2):65-70. PubMed ID: 10350185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity.
    Kharasch ED; Hankins DC; Taraday JK
    Drug Metab Dispos; 2000 Jan; 28(1):28-33. PubMed ID: 10611136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High variability of nitrosamine metabolism among individuals: role of cytochromes P450 2A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans.
    Camus AM; Geneste O; Honkakoski P; Béréziat JC; Henderson CJ; Wolf CR; Bartsch H; Lang MA
    Mol Carcinog; 1993; 7(4):268-75. PubMed ID: 8352885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular modelling of the human cytochrome P450 isoform CYP2A6 and investigations of CYP2A substrate selectivity.
    Lewis DF; Dickins M; Lake BG; Eddershaw PJ; Tarbit MH; Goldfarb PS
    Toxicology; 1999 Mar; 133(1):1-33. PubMed ID: 10413191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diversity of selective environmental substrates for human cytochrome P450 2A6: alkoxyethers, nicotine, coumarin, N-nitrosodiethylamine, and N-nitrosobenzylmethylamine.
    Le Gal A; Dréano Y; Lucas D; Berthou F
    Toxicol Lett; 2003 Sep; 144(1):77-91. PubMed ID: 12919726
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CDNA cloning, heterologous expression, and characterization of rat intestinal CYP2J4.
    Zhang QY; Ding X; Kaminsky LS
    Arch Biochem Biophys; 1997 Apr; 340(2):270-8. PubMed ID: 9143331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human halothane metabolism, lipid peroxidation, and cytochromes P(450)2A6 and P(450)3A4.
    Kharasch ED; Hankins DC; Fenstamaker K; Cox K
    Eur J Clin Pharmacol; 2000; 55(11-12):853-9. PubMed ID: 10805064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coumarin metabolism by rat esophageal microsomes and cytochrome P450 2A3.
    von Weymarn LB; Murphy SE
    Chem Res Toxicol; 2001 Oct; 14(10):1386-92. PubMed ID: 11599930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.